The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Name

7 Oct 2022 07:00

RNS Number : 0953C
Honeycomb Investment Trust PLC
07 October 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

THIS IS AN ANNOUNCEMENT AND NOT A PROSPECTUS OR EQUIVALENT DOCUMENT. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, ANY OFFER, INVITATION OR RECOMMENDATION TO PURCHASE, SELL OR SUBSCRIBE FOR ANY SECURITIES IN ANY JURISDICTION AND NEITHER THE ISSUE OF THE INFORMATION NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF OR BE RELIED UPON IN CONNECTION WITH, OR ACT AS AN INDUCEMENT TO ENTER INTO, ANY INVESTMENT ACTIVITY

 

FOR IMMEDIATE RELEASE

7 October 2022

Honeycomb Investment Trust plc ("Honeycomb")

Change of Name

Honeycomb announces, following the completion of the all share combination between Honeycomb and Pollen Street Capital Holdings Limited, that it has changed its name to Pollen Street plc. The change of name, which took effect yesterday, 6 October 2022, has been approved by the Board of Directors in accordance with Honeycomb's Articles of Association. Honeycomb's shares will trade under the new name on the London Stock Exchange from 8.00 a.m. London time on 10 October 2022. The Company's trading instrument display mnemonic ("TIDM") will also change from HONY to POLN with effect from 8.00 a.m. London time on 10 October 2022. The ISIN and SEDOL numbers will remain unchanged. As of today, the Company's website address has been amended to https://www.pollenstreetgroup.com/.

Enquiries:

Cenkos - Financial Adviser, Sponsor and Joint Broker to Honeycomb

Tunga Chigovanyika

Daniel BalabanoffJustin Zawoda Martin

+44 20 7397 8900

 

BofA Securities - Financial Adviser to Honeycomb Geoff Iles

Oliver Elias

Charles Pitt Ford

+44 20 7628 1000

Liberum - Joint Broker

Chris Clarke

+44 20 3100 2000

 

Barclays Bank PLC - Joint Broker Neal WestDion Di MiceliChris MaddersonStuart Muress+44 (0) 20 7623 2323

FGS Global - Communications Adviser

Chris Sibbald

+44 20 7251 3801

 

About Honeycomb

Honeycomb is a UK-listed closed ended investment trust dedicated to providing investors with access to asset backed lending opportunities, with potential to generate high income returns, together with strong capital preservation.

About Pollen Street

Pollen Street was founded in 2013 and is an independent, alternative investment management company dedicated to investing in the financial and business services sectors. Pollen Street has extensive experience investing in both credit and private equity strategies and has a strong and consistent track record of delivering top tier returns. A wholly owned subsidiary of Pollen Street serves as Honeycomb's investment manager.

Additional information

Merrill Lynch International ("BofA Securities"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the FCA and the PRA in the United Kingdom, is acting as financial adviser exclusively for Honeycomb and for no one else and will not be responsible to anyone other than Honeycomb for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement. Neither BofA Securities, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of BofA Securities in connection with this announcement, the Prospectus, or any statement contained herein or otherwise.

Cenkos Securities plc ("Cenkos"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as financial adviser and sponsor for Honeycomb and for no one else in connection with the Combination and Admission and will not be responsible to anyone other than Honeycomb for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement or any other arrangement referred to, or information contained in, the Prospectus. Neither Cenkos, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Cenkos in connection with this announcement, the Prospectus, or any statement contained herein or otherwise.

Liberum Capital Limited ("Liberum") is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for Honeycomb and no-one else in connection with the proposed Combination and will not be responsible to anyone other than the Honeycomb for providing the protections afforded to the clients of Liberum, as applicable, or for affording advice in relation to the contents of the announcement, the Prospectus, or any matters referred to therein. Nothing in this paragraph shall serve to exclude or limit any responsibilities Liberum may have under the Financial Services and Markets Act 2000 or the regulatory regime established thereunder.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANFSDESMEESESS
Date   Source Headline
21st Sep 20187:01 amRNSAugust Factsheet
21st Sep 20187:00 amRNSNet Asset Value
5th Sep 20187:00 amRNSDividend Declaration
5th Sep 20187:00 amRNSHalf-year Report 2018
21st Aug 20187:00 amRNSMonthly Update - 31st July 2018
21st Aug 20187:00 amRNSNet Asset Value - 31st July 2018
20th Jul 20187:00 amRNSMonthly Update - Factsheet June 30th 2018
20th Jul 20187:00 amRNSNet Asset Value - June 30th 2018
21st Jun 20183:17 pmRNSNet Asset Value - 31st May 2018 - Replacement
21st Jun 20187:00 amRNSMonthly Update - May 2018
21st Jun 20187:00 amRNSNet Asset Value(s)
8th Jun 20185:42 pmRNSResult of AGM
25th May 20185:29 pmRNSNet Asset Value - 30 April 2018 - Replacement
21st May 20187:00 amRNSNet Asset Value - 30 April 2018
21st May 20187:00 amRNSMonthly Update - 30 April 2018
9th May 20184:28 pmRNSAGM and Financial Statements Notification-Dec 2017
2nd May 20187:00 amRNSHolding(s) in Company
30th Apr 20187:00 amRNSAnnual Report and Audited Financial Statements
25th Apr 20187:00 amRNSHolding(s) in Company - TR1 Announcement
19th Apr 20184:30 pmRNSResult of Placing
19th Apr 20187:00 amRNSProposed Placing
16th Apr 20187:25 amRNSChange of Registered Office
12th Apr 20187:00 amRNSMonthly Update - March 2018
12th Apr 20187:00 amRNSDividend Declaration
12th Apr 20187:00 amRNSNet Asset Value - March 2018
5th Apr 201810:00 amRNSHolding(s) in Company - TR1 Notification
21st Mar 20187:00 amRNSMonthly update - February 28th 2018
21st Mar 20187:00 amRNSNet Asset Value - February 2018
8th Mar 20184:00 pmRNSSupplementary Prospectus
21st Feb 20187:00 amRNSMonthly Update - 31st January 2018
21st Feb 20187:00 amRNSNet Asset Value(s)
21st Feb 20187:00 amRNSDividend Declaration
23rd Jan 20187:00 amRNSHolding(s) in Company - TR1 Notification
22nd Jan 20187:00 amRNSMonthly Update - December 2017
22nd Jan 20187:00 amRNSNet Asset Value(s)
21st Dec 20177:00 amRNSMonthly Update - November
21st Dec 20177:00 amRNSNet Asset Value(s)
28th Nov 20177:00 amRNSHolding(s) in Company - TR-1 Notification
21st Nov 20172:20 pmRNSDividend Declaration - Replacement
21st Nov 20177:00 amRNSMonthly Update - October 2017
21st Nov 20177:00 amRNSNet Asset Value(s) - October 2017
21st Nov 20177:00 amRNSDividend Declaration
16th Nov 20177:00 amRNSHolding(s) in Company - TR-1 Notification
20th Oct 20177:00 amRNSMonthly Update - September 2017
20th Oct 20177:00 amRNSNet Asset Value - September 2017
21st Sep 20177:00 amRNSMonthly update - August 2017
21st Sep 20177:00 amRNSNet Asset Value - August 2017
31st Aug 20177:00 amRNSDividend Declaration - Q2 2017
31st Aug 20177:00 amRNSFinancial Statement Announcement
31st Aug 20177:00 amRNSHalf-year Report 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.